Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
Enveda , a biotech startup that uses AI to discover new drugs in the natural world, has raised a $311 million Series E at a $2 billion valuation. The fresh funding, which was led by Catalio Capital Management, with participation from Iconiq and others, doubles the valuation Enveda achieved 12 months ago.
The idea behind Enveda is that powerful medicines could be harnessed from plants and microbes, rather than synthesized from scratch in a lab. Viswa Colluru, an early employee of Recursion Pharmaceuticals, founded Enveda in 2019 to speed up the process of discovering these new drugs using AI and other techniques.
While AI hasn’t yet produced any FDA-approved drugs, Enveda is among the wave of companies advancing AI-discovered candidates into human clinical trials. The startup is currently testing several drugs in patients, including one targeting severe skin conditions and another designed to help maintain weight loss after stopping GLP-1s.
Your next big connection is at Disrupt. Connect with 10,000+ founders, VCs, operators, and tech leaders. Explore tomorrow’s breakthroughs, hear what’s shaping tech today, and save up to $200 by Sept. 25 at 11:59 p.m. PT.
StrictlyVC at TechCrunch Disrupt 2026: Inside the changing rules of venture capital
Snorkel AI triples valuation to $3.5B as demand for AI training data booms
Nscale’s IPO will test Wall Street’s appetite for concentrated AI bets once again
Latest in Biotech & Health
Anthropic says its biology lab has already found something big
Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
3 days left to save up to $200 and make impactful connections at TechCrunch Disrupt 2026
Verified source · TechCrunch
Reported by TechCrunch. Open the original for full media and formatting.
More in Funding
All news
FundingMultiples Leads $150 Mn Funding Round In Brahma AI
Multiples Alternate Asset Management has led a $150 Mn funding round in Prime Focus-backed AI audiovisual content platform Brahma AI,…
Read at Inc42
FundingEma raises $77M as AI starts eating into enterprise software and services
Ema has raised $140 million to date and has more than 50 enterprise customers, including Google and Microsoft.
Read at TechCrunch
FundingParamount will need to release way more movies to make this merger work
Now that Paramount has reached a settlement with the 12 states that were suing to block its $110 billion merger with Warner Bros. Discovery (WBD), the studio is even closer to becoming one of the world's biggest production houses. In addition to spending at least $300 million mo…
Read at The Verge
FundingSnorkel AI triples valuation to $3.5B as demand for AI training data booms
The seven-year-old startup has raised a $350 million Series E to fuel its data-as-a-service approach.
Read at TechCrunch